Teladoc Health (TDOC) Price Target Increased to $80.00 by Analysts at Craig Hallum
Teladoc Health (NYSE:TDOC) had its price target raised by Craig Hallum from $70.00 to $80.00 in a report published on Monday, The Fly reports. They currently have a buy rating on the health services provider’s stock.
A number of other analysts also recently weighed in on TDOC. Berenberg Bank started coverage on shares of Teladoc Health in a report on Monday, July 9th. They issued a buy rating and a $72.00 target price on the stock. KeyCorp boosted their target price on shares of Teladoc Health from $50.00 to $70.00 and gave the stock an overweight rating in a report on Monday, July 9th. Jefferies Financial Group set a $74.00 target price on shares of Teladoc Health and gave the stock a buy rating in a report on Wednesday, July 11th. Citigroup boosted their target price on shares of Teladoc Health to $80.00 and gave the stock a buy rating in a report on Thursday, July 19th. Finally, Canaccord Genuity restated a buy rating and issued a $70.00 target price (up from $63.00) on shares of Teladoc Health in a report on Wednesday, July 25th. One investment analyst has rated the stock with a sell rating, five have given a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company’s stock. The company currently has a consensus rating of Buy and an average price target of $81.95.
Shares of NYSE TDOC opened at $69.95 on Monday. The company has a debt-to-equity ratio of 0.58, a quick ratio of 3.14 and a current ratio of 3.14. The firm has a market capitalization of $6.01 billion, a price-to-earnings ratio of -42.39 and a beta of 0.57. Teladoc Health has a 52-week low of $27.30 and a 52-week high of $89.05.
In related news, insider Adam C. Vandervoort sold 5,551 shares of Teladoc Health stock in a transaction dated Monday, October 8th. The shares were sold at an average price of $73.83, for a total transaction of $409,830.33. Following the completion of the transaction, the insider now directly owns 2,934 shares of the company’s stock, valued at approximately $216,617.22. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Lewis Levy sold 1,285 shares of Teladoc Health stock in a transaction dated Monday, October 15th. The stock was sold at an average price of $67.00, for a total transaction of $86,095.00. Following the transaction, the insider now directly owns 1,285 shares of the company’s stock, valued at $86,095. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 131,706 shares of company stock valued at $9,953,679. 3.95% of the stock is owned by corporate insiders.
Several hedge funds have recently added to or reduced their stakes in TDOC. Garner Asset Management Corp purchased a new stake in Teladoc Health in the 2nd quarter valued at about $200,000. Pier 88 Investment Partners LLC purchased a new stake in Teladoc Health in the 2nd quarter valued at about $201,000. Aperio Group LLC purchased a new stake in Teladoc Health in the 2nd quarter valued at about $201,000. California Public Employees Retirement System purchased a new stake in Teladoc Health in the 2nd quarter valued at about $203,000. Finally, Biondo Investment Advisors LLC purchased a new stake in Teladoc Health in the 2nd quarter valued at about $205,000.
Teladoc Health Company Profile
Teladoc Health, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.